| name | icsm-avoid-tt-for-depressive-disorders |
| description | Testosterone monotherapy is not an effective treatment for clinical depressive disorders in hypogonadal men and should not be used for that purpose. Consider this when a patient presents with depressive mood and low testosterone, questioning whether testosterone will improve depression or if depression should be treated separately. |
Avoid testosterone therapy alone for treating clinical depressive disorders
STEP 1 — Gather Information
Collect a structured depression assessment (e.g., PHQ-9), morning total testosterone level (fasting, 07:00–11:00), and document hypogonadism symptoms (low libido, erectile dysfunction, fatigue, decreased vigor). Rule out medical mimics of depression (thyroid disorders, anemia, medication effects).
STEP 2 — Rule In / Rule Out
Is a clinical depressive disorder diagnosed per DSM-5/ICD-10 criteria? If YES, proceed to Step 3; if NO, consider testosterone therapy for hypogonadism symptoms (if confirmed) and manage accordingly.
STEP 3 — Classify or Stratify
Classify depression severity using PHQ-9: mild (5–9), moderate (10–14), moderately severe (15–19), severe (20–27). If mild, consider psychotherapy or watchful waiting; if moderate-severe or greater, initiate evidence-based antidepressant therapy or refer to mental health specialist.
STEP 4 — Decide
Do not prescribe testosterone monotherapy for depression; treat depression with guideline-concordant antidepressants/psychotherapy, and consider testosterone therapy only for hypogonadism symptoms after depressive disorder is adequately treated.
Clinical Guardrails / Mimics / Pitfalls
Do not attribute depressive symptoms solely to low testosterone; avoid using TTh as a sole antidepressant; monitor for worsening depression or emergent suicidality; ensure depression is treated per psychiatric guidelines before addressing hypogonadism.
Concrete Clinical Example
A 52-year-old man reports fatigue, low libido, and morning total testosterone 8 nmol/L. PHQ-9 score is 15 (moderately severe depression). He asks if testosterone will improve his mood. According to the guideline, do not start testosterone therapy alone; initiate an SSRI, reassess mood in 4–6 weeks, and consider testosterone only for hypogonadism if depressive symptoms remit.
Source: Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024), Box2 Recommendation 14, 2025, https://doi.org/10.1093/sxmrev/qeaf036
